Skip to main content

Actuate Therapeutics, Inc.

ACTU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001652935

In the last 90 days, Actuate Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 62 institutions reported holding it in 13F filings for Q2 2026, worth $20.6M in total; no superinvestor holds it.

Politicians who traded ACTU

No member of Congress has reported a trade in Actuate Therapeutics, Inc. shares or options since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.